Related references
Note: Only part of the references are listed.Phosphotyrosine couples peptide binding and SHP2 activation via a dynamic allosteric network
Michelangelo Marasco et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2021)
Pathogenic PTPN11 variants involving the poly-glutamine Gln255-Gln256-Gln257 stretch highlight the relevance of helix B in SHP2's functional regulation
Simone Martinelli et al.
HUMAN MUTATION (2020)
Molecular mechanism of SHP2 activation by PD-1 stimulation
M. Marasco et al.
SCIENCE ADVANCES (2020)
Structural Determinants of Phosphopeptide Binding to the N-Terminal Src Homology 2 Domain of the SHP2 Phosphatase
Massimiliano Anselmi et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2020)
Recent Advances of SHP2 Inhibitors in Cancer Therapy: Current Development and Clinical Application
Xinrui Yuan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Cytosolic delivery of peptidic STAT3 SH2 domain inhibitors
Robert A. Cerulli et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2020)
Medicinal chemistry strategies for the development of protein tyrosine phosphatase SHP2 inhibitors and PROTAC degraders
Kai Tang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Identification of TNO155, an Allosteric SHP2 Inhibitor for the Treatment of Cancer
Matthew J. LaMarche et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
From Pyrazolones to Azaindoles: Evolution of Active-Site SHP2 Inhibitors Based on Scaffold Hopping and Bioisosteric Replacement
Yelena Mostinski et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Phosphotyrosine isosteres: past, present and future
Robert A. Cerullia et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2020)
Specificity and regulation of phosphotyrosine signaling through SH2 domains
Michelangelo Marasco et al.
JOURNAL OF STRUCTURAL BIOLOGY-X (2020)
Optimization of Fused Bicyclic Allosteric SHP2 Inhibitors
Jeffrey T. Bagdanoff et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
6-Amino-3-methylpyrimidinones as Potent, Selective, and Orally Efficacious SHP2 Inhibitors
Patrick Sarver et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Small Molecule Inhibitor that Stabilizes the Autoinhibited Conformation of the Oncogenic Tyrosine Phosphatase SHP2
Xiaoqin Wu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Phosphorylation of the phosphatase PTPROt at Tyr399 is a molecular switch that controls osteoclast activity and bone mass in vivo
Lee Roth et al.
SCIENCE SIGNALING (2019)
The Current State of Peptide Drug Discovery: Back to the Future?
Antoine Henninot et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Off-target inhibition by active site-targeting SHP2 inhibitors
Ryouhei Tsutsumi et al.
FEBS OPEN BIO (2018)
Mechanism of Folding and Binding of the N-Terminal SH2 Domain from SHP2
Daniela Bonetti et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2018)
Phosphatases start shedding their stigma of undruggability
Asher Mullard
NATURE REVIEWS DRUG DISCOVERY (2018)
Structural reorganization of SHP2 by oncogenic mutations and implications for oncoprotein resistance to allosteric inhibition
Jonathan R. LaRochelle et al.
NATURE COMMUNICATIONS (2018)
Protein-Protein Interactions: Emerging Oncotargets in the RAS-ERK Pathway
Rocio Garcia-Gomez et al.
TRENDS IN CANCER (2018)
Allosteric Inhibitors of SHP2 with Therapeutic Potential for Cancer Treatment
Jingjing Xie et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Differential Mechanisms for SHP2 Binding and Activation Are Exploited by Geographically Distinct Helicobacter pylori CagA Oncoproteins
Takeru Hayashi et al.
CELL REPORTS (2017)
Allosteric Inhibition of SHP2: Identification of a Potent, Selective, and Orally Efficacious Phosphatase Inhibitor
Jorge Garcia Fortanet et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases
Ying-Nan P. Chen et al.
NATURE (2016)
SHP2 sails from physiology to pathology
Mylene Tajan et al.
EUROPEAN JOURNAL OF MEDICAL GENETICS (2015)
PTPN11 Is a Central Node in Intrinsic and Acquired Resistance to Targeted Cancer Drugs
Anirudh Prahallad et al.
CELL REPORTS (2015)
Molecular Basis of Gain-of-Function LEOPARD Syndrome-Associated SHP2 Mutations
Zhi-Hong Yu et al.
BIOCHEMISTRY (2014)
Efficient Delivery of Cell Impermeable Phosphopeptides by a Cyclic Peptide Amphiphile Containing Tryptophan and Arginine
Amir Nasrolahi Shirazi et al.
MOLECULAR PHARMACEUTICS (2013)
A rheostat for immune responses: the unique properties of PD-1 and their advantages for clinical application
Taku Okazaki et al.
NATURE IMMUNOLOGY (2013)
Dissection of the BCR-ABL signaling network using highly specific monobody inhibitors to the SHP2 SH2 domains
Fern Sha et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Molecular Mechanisms of SH2-and PTB-Domain-Containing Proteins in Receptor Tyrosine Kinase Signaling
Melany J. Wagner et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2013)
Counteracting Effects Operating on Src Homology 2 Domain-containing Protein-tyrosine Phosphatase 2 (SHP2) Function Drive Selection of the Recurrent Y62D and Y63C Substitutions in Noonan Syndrome
Simone Martinelli et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
NIH Image to ImageJ: 25 years of image analysis
Caroline A. Schneider et al.
NATURE METHODS (2012)
Superbinder SH2 Domains Act as Antagonists of Cell Signaling
Tomonori Kaneko et al.
SCIENCE SIGNALING (2012)
Non-lineage/stage-restricted effects of a gain-of-function mutation in tyrosine phosphatase Ptpn11 (Shp2) on malignant transformation of hematopoietic cells
Dan Xu et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Disorders of dysregulated signal traffic through the RAS-MAPK pathway: phenotypic spectrum and molecular mechanisms
Marco Tartaglia et al.
YEAR IN HUMAN AND MEDICAL GENETICS: NEW TRENDS IN MENDELIAN GENETICS (2010)
g_wham-A Free Weighted Histogram Analysis Implementation Including Robust Error and Autocorrelation Estimates
Jochen S. Hub et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2010)
Monomer-Dimer Equilibrium in Glutathione Transferases: A Critical Re-Examination
Raffaele Fabrini et al.
BIOCHEMISTRY (2009)
Identification of Shc Src Homology 2 Domain-Binding Peptoid-Peptide Hybrids
Won Jun Choi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Diverse driving forces underlie the invariant occurrence of the T42A, E139D, I282V and T468M SHP2 amino acid substitutions causing Noonan and LEOPARD syndromes
Simone Martinelli et al.
HUMAN MOLECULAR GENETICS (2008)
Defining the specificity space of the human Src homology 2 domain
Haiming Huang et al.
MOLECULAR & CELLULAR PROTEOMICS (2008)
Shp2 knockdown and Noonan/LEOPARD mutant Shp2-induced gastrulation defects
Chris Jopling et al.
PLOS GENETICS (2007)
Synthesis and evaluation of tripodal peptide analogues for cellular delivery of phosphopeptides
Guofeng Ye et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Counterion-mediated membrane penetration:: Cationic cell-penetrating peptides overcome Born energy barrier by ion-pairing with phospholipids
Elin K. Esbjorner et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2007)
Structural and functional effects of disease-causing amino acid substitutions affecting residues Ala72 and Glu76 of the protein tyrosine phosphatase SHP-2
Gianfranco Bocchinfuso et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2007)
Canonical sampling through velocity rescaling
Giovanni Bussi et al.
JOURNAL OF CHEMICAL PHYSICS (2007)
Optimization of the cellular import of functionally active SH2-domain-interacting phosphopeptides
A. Kertesz et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2006)
Sequence specificity of SHP-1 and SHP-2 Src homology 2 domains - Critical roles of residues beyond the pY+3 position
Diana Imhof et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
The human and mouse complement of SH2 domain proteins -: Establishing the boundaries of phosphotyrosine signaling
Bernard A. Liu et al.
MOLECULAR CELL (2006)
Diversity and functional consequences of germline and somatic PTPN11 mutations in human disease
M Tartaglia et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2006)
AMBER force-field parameters for phosphorylated amino acids in different protonation states: phosphoserine, phosphothreonine, phosphotyrosine, and phosphohistidine
N Homeyer et al.
JOURNAL OF MOLECULAR MODELING (2006)
Design and synthesis of phosphonodifluoromethyl phenylalanine (F(2)Pmp): A useful phosphotyrosyl mimetic
Terrence R. Burke
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2006)
The mutational spectrum of PTPN11 in juvenile myelomonocytic leukemia and Noonan syndrome/myeloproliferative disease
CP Kratz et al.
BLOOD (2005)
Diverse biochemical properties of Shp2 mutants
H Keilhack et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
The SH2 domain: versatile signaling module and pharmaceutical target
K Machida et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2005)
Mouse model of Noonan syndrome reveals cell type- and gene dosage-dependent effects of Ptpn11 mutation
T Araki et al.
NATURE MEDICINE (2004)
Genetic evidence for lineage-related and differentiation stage-related contribution of somatic PTPN11 mutations to leukemogenesis in childhood acute leukemia
M Tartaglia et al.
BLOOD (2004)
Structural basis for recruitment of the adaptor protein APS to the activated insulin receptor
JJ Hu et al.
MOLECULAR CELL (2003)
Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia
M Tartaglia et al.
NATURE GENETICS (2003)
Fluorescence polarization competition assay: The range of resolvable inhibitor potency is limited by the affinity of the fluorescent ligand
XY Huang
JOURNAL OF BIOMOLECULAR SCREENING (2003)
Grouping of multiple-lentigines/LEOPARD and Noonan syndromes on the PTPN11 gene
MC Digilio et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2002)
SH2 domains from suppressor of cytokine signaling-3 and protein tyrosine phosphatase SHP-2 have similar binding specificities
D De Souza et al.
BIOCHEMISTRY (2002)
Receptor-specific regulation of phosphatidylinositol 3′-kinase activation by the protein tyrosine phosphatase Shp2
SQ Zhang et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein
H Higashi et al.
SCIENCE (2002)
Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome
M Tartaglia et al.
NATURE GENETICS (2001)
Co-clustering of Fcγ and B cell receptors induces dephosphorylation of the Grb2-associated binder 1 docking protein
G Koncz et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2001)
Phosphotyrosines 627 and 659 of Gab1 constitute a bisphosphoryl tyrosine-based activation motif (BTAM) conferring binding and activation of SHP2
JM Cunnick et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Share Paper
